Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Thursday, February 5, 2015

Prices for the miracle drugs that cure Hepatitis C are collapsing

When California based Gilead Sciences announced a breakthrough treatment in late 2013 that cures most kinds of Hepatitis C, people were outraged at the cost: $84,000 in total, or nearly $1,000 a pill.

There are more expensive drugs, but Gilead Science’s hepatitis drugs’—Sovaldi and Harvoni—combination of eye-popping price, sales, and patient population (100 million plus worldwide) is unprecedented (paywall).
 
But on February 3rd, Gilead announced in its quarterly earnings call that it expects to cut the price of its Hepatitis C drugs an average of 46% this year in the US. That’s double last year’s discount. Some government plans will pay less than half the list price for Harvoni (a Gilead follow up treatment that combines Sovaldi’s active ingredient with another drug).

Read more...

1 comment:

  1. Big thanks to Dr. Iyabiye who treated/cure my brother of chronic HEPATITIS B and Cirrhosis. My brother was diagnosed of the disease last year and we tried several antiviral medications but they were all to no avail. At a point my brother developed swollen stomach and loss of appetite, I went online out of frustration for a new medication and I came across this doctor’s recommendation. I reached out to him and my brother was cured after the completion of the medicine and tested negative at the hospital. Dr. iyabiye’s contact: call/whatsapp: +234-815-857-7300 and email: iyabiyehealinghome@gmail.com

    ReplyDelete